Bio Medica Laboratories Limited (NSE:BMLL)
India · Delayed Price · Currency is INR 141.45
+2.75 (1.98%)
At close: Jul 27, 2026
Bio Medica Laboratories Revenue
In the fiscal year ending March 31, 2026, Bio Medica Laboratories had annual revenue of 431.13M INR with 12.88% growth.
Revenue
431.13M
Revenue Growth
+12.88%
P/S Ratio
4.64
Revenue / Employee
10.32M
Employees
37
Market Cap
1.77B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 431.13M | 49.18M | 12.88% |
| Mar 31, 2025 | 381.95M | 229.46M | 150.47% |
| Mar 31, 2024 | 152.49M | -9.79M | -6.03% |
| Mar 31, 2023 | 162.28M | -49.97M | -23.54% |
| Mar 31, 2022 | 212.25M | 83.00M | 64.21% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.34B |
| Bal Pharma | 3.12B |
| Parnax Lab | 2.49B |
| Sat Kartar Life | 2.01B |
| Gennex Laboratories | 1.73B |
| Kerala Ayurveda | 1.31B |
| Oxygenta Pharmaceutical | 1.13B |
| Accretion Pharmaceuticals | 898.18M |